Literature DB >> 6237568

Secondary hypertrophic cardiomyopathy in infancy and childhood.

L E Alday, E Moreyra.   

Abstract

In 12 infants and children with hypertrophic cardiomyopathy (HCM), seen during a 5-year period, the incidence of the idiopathic or primary form was similar to that secondary to systemic disease. Five of the six patients with secondary HCM are reported. Pompe's disease, Friedreich's ataxia, and Noonan's syndrome were seen in one each. There were two patients with lentiginosis. The diagnosis of HCM and of the metabolic disorder was made simultaneously in the patient with Pompe's disease. In two patients, one with Friedreich's ataxia and the other with lentiginosis, the diagnosis of HCM preceded the manifestations of the associated disorder. The other two patients were referred to rule out heart disease. The diagnosis of HCM in infancy and childhood should be considered with the possibility of being a secondary form, and patients with known associations with HCM should be referred for early diagnosis of heart conditions.

Entities:  

Mesh:

Year:  1984        PMID: 6237568     DOI: 10.1016/0002-8703(84)90466-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis).

Authors:  B D Coppin; I K Temple
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  Primary or secondary cardiomyopathies?

Authors:  A A Schmaltz
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

3.  Woolly hair and palmoplantar hyperkeratosis may present with hypertrophic cardiomyopathy.

Authors:  A Peirone; E Bruno; N Rossi; L E Alday
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 4.  Two cases of Pompe's disease: case report and review of literature.

Authors:  A Jegadeeswari; V Amuthan; R A Janarthanan; S Murugan; S Balasubramanian
Journal:  Indian Heart J       Date:  2012-04-28

5.  Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure.

Authors:  Pablo Cordero; Victoria N Parikh; Elizabeth T Chin; Ayca Erbilgin; Michael J Gloudemans; Ching Shang; Yong Huang; Alex C Chang; Kevin S Smith; Frederick Dewey; Kathia Zaleta; Michael Morley; Jeff Brandimarto; Nicole Glazer; Daryl Waggott; Aleksandra Pavlovic; Mingming Zhao; Christine S Moravec; W H Wilson Tang; Jamie Skreen; Christine Malloy; Sridhar Hannenhalli; Hongzhe Li; Scott Ritter; Mingyao Li; Daniel Bernstein; Andrew Connolly; Hakon Hakonarson; Aldons J Lusis; Kenneth B Margulies; Anna A Depaoli-Roach; Stephen B Montgomery; Matthew T Wheeler; Thomas Cappola; Euan A Ashley
Journal:  Nat Commun       Date:  2019-06-24       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.